• Zum Hauptinhalt springen
  • Zum Footer springen
  • Deutsch - de
  • English - en

    SyNergy - Mu...

    • Über uns
      • Über uns
      • Maßnahmen
      • Mitglieder
      • Cluster Management
      • PhD und Postdoc-Vertreter
      • Wissenschaftlicher Beirat
      • Internationale Kooperationspartner
      • Timeline
      • Pressekit
      • Kontakt
    • Aktuelles
      • News
      • Veranstaltungen
      • Presseecho
      • Stellenausschreibungen
    • Forschung
      • Publikationen
      • Unser Forschungsschwerpunkt
      • Technology Hubs
      • "Research Spotlight"
      • Management von Forschungsdaten
      • Sustainability Initiative
      • Verhaltenskodex
    • Wissenschaft & Gesellschaft
      • Für Schulen und Schüler
      • Öffentliche Veranstaltungen
      • Podcasts
      • Videos
    • Support für Diversity & Equity
      • Newcomer Center
      • Gender Equality Program
      • Early Career Investigator Programm
    1. Home
    2. Aktuelles
    3. News
    4. Alzheimer’s disease: Amyloid drives the spread of tau by evoking neuronal hyperconnectivity
    News | 13.02.2025 | Research Spotlight

    Alzheimer’s disease: Amyloid drives the spread of tau by evoking neuronal hyperconnectivity

    The Amyloid Cascade model of Alzheimer’s disease suggests that plaques of amyloid-β (Aβ) are the primary cause of the disease and trigger other pathological changes, such as the spread of abnormal tau protein. The exact connection between amyloid and tau buildup is not clear. Researchers now found an essential piece to this puzzle: by analyzing PET and MRI imaging, they show that amyloid drives the spread of tau by evoking neuronal hyperconnectivity. 
      Research Spotlight: photo of researcher with citation on impact of research

    This is a summary of Roemer-Cassiano et al. (2025). Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer’s disease as published in Science Translational Medicine DOI: 10.1126/scitranslmed.adp2564.


    The challenge

    In Alzheimer’s disease (AD), the protein amyloid-β (Aβ) is responsible for triggering the aggregation and spread of tau pathology, resulting in neurodegeneration and cognitive decline. Previous research has shown that Aβ triggers neuronal hyperactivity and hyperconnectivity. Moreover, preclinical research has shown that tau spreads across connected neurons activity-dependently. We, therefore, wanted to examine whether neuronal hyperactivity and hypersynchronicity are some of the crucial mechanisms by which Aβ drives the spread of tau.


    Our approach

    We combined Aβ positron emission tomography (PET), resting-state functional magnetic resonance imaging, and longitudinal tau-PET in 69 cognitively normal amyloid-negative controls and 140 amyloid-positive patients across the AD spectrum. We replicated the study in an independent sample of 55 controls and 345 individuals with preclinical AD and low cortical tau-PET uptake.


    Our findings

    Our study shows that Aβ causes hyperconnectivity of temporal lobe tau epicenters to posterior brain regions that are vulnerable to tau accumulation in AD. This was replicated in the independent sample, suggesting that the emergence of Aβ-related hyperconnectivity precedes the spread of neocortical tau. We confirmed that the effect of Aβ on the faster accumulation of tau was mediated by the increases in tau epicenters to typical tau-vulnerable brain regions. This suggests that an increased connectivity is a potential causal link between Aβ and tau pathology.


    The implications

    Our findings suggest that Aβ promotes tau spreading by evoking neuronal hyperconnectivity. Targeting Aβ-related neuronal hyperconnectivity may be a therapeutic strategy to reduce the spread of tau in AD.


    Creating SyNergies

    The study was led by SyNergy member Nicolai Franzmeier who was joined by our members Robert Perneczky, Martin Dichgans, Günter Höglinger, Matthias Brendel and Sarah Jäkel. 

    Teilnehmende Universitäten
     LMU logo in white
     TUM logo in white
    Partnerinstitute
     Logo DZNE in white
    Helmholtz Munich logo in white 
     Logo Max Planck Gesellschaft 

    SyNergy wird von der Deutschen Forschungsgemeinschaft im Rahmen der deutschen Exzellenzstrategie gefördert (EXC 2145 SyNergy - ID 390857198). Die Exzellenzstrategie fördert herausragende Forschung an deutschen Universitäten. 

    Kontakt

    Munich Cluster for Systems Neurology (SyNergy)

    Feodor-Lynen-Str. 17
    81377 Munich
    +49 (0)89 4400-46497
    yüubgybcјuipxј#vfulyz mi
    Anmeldung für Redakteure
    Impressum | Datenschutz